These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15583183)

  • 1. Excess in the pharmaceutical industry.
    Angell M
    CMAJ; 2004 Dec; 171(12):1451-3. PubMed ID: 15583183
    [No Abstract]   [Full Text] [Related]  

  • 2. Looking inward: regional parallel trade as a means of bringing affordable drugs to Africa.
    Buckely M
    Seton Hall Law Rev; 2011; 41(2):625-69. PubMed ID: 21739760
    [No Abstract]   [Full Text] [Related]  

  • 3. Rx: Canadian drugs.
    Bugden S
    N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15014193
    [No Abstract]   [Full Text] [Related]  

  • 4. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS; Angell M
    New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States.
    Gagnon MA; Lexchin J
    PLoS Med; 2008 Jan; 5(1):e1. PubMed ID: 18177202
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmaceutical industry--prices and progress.
    Scherer FM
    N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432
    [No Abstract]   [Full Text] [Related]  

  • 7. Making the move into drug sales.
    Willerroider M
    Nature; 2004 Jul; 430(6998):486-7. PubMed ID: 15269778
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.
    Latham SR
    J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care.
    Work DR; Domino ME
    N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614
    [No Abstract]   [Full Text] [Related]  

  • 10. What does R&D really cost?
    Huff B
    GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507
    [No Abstract]   [Full Text] [Related]  

  • 11. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme.
    Sainsbury P
    Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: business practices. Issue brief.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448
    [No Abstract]   [Full Text] [Related]  

  • 13. What price competitiveness in the drugs industry?
    Lancet; 2003 Jul; 362(9380):257. PubMed ID: 12892949
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription-drug prices.
    Frank RG
    N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294
    [No Abstract]   [Full Text] [Related]  

  • 15. Gray marketing of pharmaceuticals.
    Chaudhry PE; Walsh MG
    J Health Care Mark; 1995; 15(3):18-22. PubMed ID: 10172516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 17. The other drug lords.
    Novak V
    Int J Health Serv; 1993; 23(2):263-73. PubMed ID: 8500946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The demise of the blockbuster?
    Cutler DM
    N Engl J Med; 2007 Mar; 356(13):1292-3. PubMed ID: 17392299
    [No Abstract]   [Full Text] [Related]  

  • 19. Why drugs cost so much.
    Noonan D
    Newsweek; 2000 Sep; 136(13):22-30. PubMed ID: 11183315
    [No Abstract]   [Full Text] [Related]  

  • 20. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    Health Care Law Mon; 2007 Aug; ():3-12. PubMed ID: 17955590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.